SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-12-000983
Filing Date
2012-03-21
Accepted
2012-03-21 08:30:45
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_032112.htm 10-K 1374153
2 EXHIBIT 10.30 exh_1030.htm EX-10.30 115320
3 EXHIBIT 23.1 exh_231.htm EX-23.1 4969
4 EXHIBIT 23.2 exh_232.htm EX-23.2 5061
5 EXHIBIT 31.1 exh_311.htm EX-31.1 11243
6 EXHIBIT 31.2 exh_312.htm EX-31.2 11607
7 EXHIBIT 32.1 exh_321.htm EX-32.1 9333
  Complete submission text file 0001171843-12-000983.txt   3006508

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT caps-20111231.xml EX-101.INS 210512
9 XBRL TAXONOMY EXTENSION SCHEMA caps-20111231.xsd EX-101.SCH 17957
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caps-20111231_cal.xml EX-101.CAL 21730
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caps-20111231_def.xml EX-101.DEF 61126
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE caps-20111231_lab.xml EX-101.LAB 143610
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caps-20111231_pre.xml EX-101.PRE 84626
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33560 | Film No.: 12704825
SIC: 2834 Pharmaceutical Preparations